178 related articles for article (PubMed ID: 35566526)
21. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of exosome-encapsulated miR-548c-5p is associated with poor prognosis in colorectal cancer.
Peng ZY; Gu RH; Yan B
J Cell Biochem; 2019 Feb; 120(2):1457-1463. PubMed ID: 30171732
[TBL] [Abstract][Full Text] [Related]
23. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
25. Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer.
Ying HQ; Chen W; Xiong CF; Wang Y; Li XJ; Cheng XX
Cancer Cell Int; 2022 Mar; 22(1):137. PubMed ID: 35346200
[TBL] [Abstract][Full Text] [Related]
26. Prothrombin time (PT) and CEA as prognostic predictive biomarkers for postoperative recurrence after curative resection in patients with stage I-III colorectal cancer: a retrospective cohort study.
Ma L; Li W; Liu N; Ding Z; Cai J; Zhang Y
Updates Surg; 2022 Jun; 74(3):999-1009. PubMed ID: 35322387
[TBL] [Abstract][Full Text] [Related]
27. Meprin α combined with CEA and CA19-9 improves prognostic prediction for surgically treated colorectal cancer patients.
Hou H; Gou X; Bu J; Su Y; Wei X; Wang X; Hou B
Int J Clin Exp Pathol; 2017; 10(10):10441-10450. PubMed ID: 31966381
[TBL] [Abstract][Full Text] [Related]
28. The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer.
Ying HQ; Sun F; Liao YC; Cai D; Yang Y; Cheng XX
Ther Adv Med Oncol; 2021; 13():17588359211022886. PubMed ID: 34262615
[TBL] [Abstract][Full Text] [Related]
29. Four circulating exosomal miRNAs as novel potential biomarkers for the early diagnosis of human colorectal cancer.
Shi Y; Zhuang Y; Zhang J; Chen M; Wu S
Tissue Cell; 2021 Jun; 70():101499. PubMed ID: 33550035
[TBL] [Abstract][Full Text] [Related]
30. Circulating Exosomal miR-150-5p and miR-99b-5p as Diagnostic Biomarkers for Colorectal Cancer.
Zhao YJ; Song X; Niu L; Tang Y; Song X; Xie L
Front Oncol; 2019; 9():1129. PubMed ID: 31750241
[No Abstract] [Full Text] [Related]
31. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis.
Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P
Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905
[TBL] [Abstract][Full Text] [Related]
32. Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
Zheng X; Fan L; Zhou P; Ma H; Huang S; Yu D; Zhao L; Yang S; Liu J; Huang A; Cai C; Dai X; Zhang T
Transl Oncol; 2017 Jun; 10(3):431-441. PubMed ID: 28448959
[TBL] [Abstract][Full Text] [Related]
33. Carbohydrate antigen 19-9 plus carcinoembryonic antigen for prognosis in colorectal cancer: An observational study.
Lee JO; Kim M; Lee JH; Kim Y; Lim HK; Kwon YH; Shin R; Park JW; Ryoo SB; Park KJ; Jeong SY
Colorectal Dis; 2023 Feb; 25(2):272-281. PubMed ID: 36226485
[TBL] [Abstract][Full Text] [Related]
34. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
36. Upregulated serum miR-675 predicts poor prognosis for colorectal cancer.
Zhang R; Xu J; Zhao J; Liu F
Int J Clin Exp Pathol; 2017; 10(7):8043-8049. PubMed ID: 31966656
[TBL] [Abstract][Full Text] [Related]
37. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer.
Sun B; Li Y; Zhou Y; Ng TK; Zhao C; Gan Q; Gu X; Xiang J
J Cell Physiol; 2019 Feb; 234(2):1416-1425. PubMed ID: 30078189
[TBL] [Abstract][Full Text] [Related]
38. Circulating exosomal microRNAs as biomarkers of colon cancer.
Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
[TBL] [Abstract][Full Text] [Related]
39. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
40. Identification of a circulating microRNA signature for colorectal cancer detection.
Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ
PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
